AI Article Synopsis

  • The study describes a unique case of hereditary spastic paraplegia (HSP) with a complex presentation of dopa-responsive dystonia (DRD) in an 11-year-old boy, diagnosed using whole exome sequencing.
  • The patient exhibited symptoms like progressive dystonia and gait issues, initially responding well to levodopa but later experiencing complications like wearing-off effects and dyskinesia.
  • Brain imaging revealed structural brain changes, and genetic analysis identified mutations linked to HSP; treatment with GPi DBS surgery significantly improved his condition.

Article Abstract

Background: The aim of this study was to describe a case of hereditary spastic paraplegia (HSP) resulting from mutations, presenting with a complex phenotype of dopa-responsive dystonia (DRD), diagnosed using whole exome sequencing (WES). HSP resulting from typically presents with spasticity, cognitive impairment, and radiological evidence of thin corpus callosum. Initial presentation with DRD has not been previously reported on.

Methods: This 11-year-old boy with delay in fine motor skills, presented at 8 years of age with progressive, generalized dystonia with diurnal variation, bradykinesia, and stiff gait. There was marked improvement in dystonia with levodopa, but he soon developed wearing-off phenomenon and l-dopa-induced dyskinesia. Family history was unremarkable.

Results: Brain MRI showed thinning of the anterior corpus callosum with periventricular white matter changes. I-ioflupane single-photon emission coupled tomography showed bilateral severe presynaptic dopamine deficiency. WES identified transheterozygous allelic variants in the on chromosome 15, including a truncating STOP mutation (p.E1630X) and a second heterozygous coding variant (p.L2300R). Dystonia improved with globus pallidus internus (GPi) DBS surgery.

Conclusions: HSP resulting from should be considered in the differential diagnosis of a patient presenting with DRD, parkinsonism, and spasticity. This case expands the HSP genotype and phenotype. GPi DBS may be a therapeutic option in selected patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183009PMC
http://dx.doi.org/10.1002/mdc3.12144DOI Listing

Publication Analysis

Top Keywords

complex phenotype
8
dopa-responsive dystonia
8
corpus callosum
8
gpi dbs
8
dystonia
5
mutations associated
4
associated complex
4
phenotype resembling
4
resembling dopa-responsive
4
dystonia background
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!